Quantcast

Latest blood clots Stories

2014-07-19 23:02:12

With Over 100 Testosterone Lawsuits Awaiting Litigation in the U.S., Health Canada Has Issued A Safety Review Warning of Possible Cardiac Risks Associated With Testosterone Treatment Drugs Columbus, OH (PRWEB) July 19, 2014 Wright & Schulte LLC has learned that Health Canada has issued a warning to patients and healthcare professionals of the potential life-threatening heart and blood vessel problems associated with testosterone replacement therapy products. The Canadian regulatory...

2014-07-17 23:05:29

Required Change Reflects Reports of Additional Clotting Not Related to Condition Covered by Current Warnings DALLAS (PRWEB) July 17, 2014 The U.S. Food & Drug Administration (FDA) has ordered testosterone therapy drug makers to provide additional warnings in regard to blood clots to those already in place, the national law firm of Baron and Budd reports. This development occurs as federal litigation involving testosterone treatment lawsuits proceed in the U.S. District Court, Northern...

2014-07-07 23:06:46

The Number of Testosterone Treatment Lawsuits Filed Alleging Heart Attacks, Strokes, And Other Cardiac Events Were Due To Testosterone Therapy Drugs Such as AndroGel and Androderm Has Grown to 98, Reports Wright & Schulte LLC Columbus, OH (PRWEB) July 07, 2014 Testosterone treatment lawsuits continue to mount as the number of filing has double in the last month. Wright & Schulte LLC notes that as of June 16th, there are 98 testosterone lawsuits filed against the makers of...

2014-06-24 08:30:22

FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) announced late last week there has been another risk linked to testosterone treatments. The FDA now requires manufacturers of testosterone or low-T products to add a general label warning about the increased risk for blood clots in veins to their prescription testosterone treatments. Blood clots in the veins, also known as venous...

FDA Orders Testosterone Supplement Makers To Include Blood Clot Warnings
2014-06-22 08:51:08

redOrbit Staff & Wire Reports – Your Universe Online The US Food and Drug Administration (FDA) is now requiring manufacturers of testosterone supplements to include a general warning label about the risk of blood clots in the veins, various media outlets reported on Friday. While testosterone products already carry warning labels pertaining to a risk of clots associated with polycythemia, which involved an abnormal increase in red blood cells after use of such supplements, Reuters...

2014-06-20 23:01:14

With over 100 Testosterone Treatment Lawsuits Pending Litigation, The FDA Continues Its Investigation Into The Potential Health Risks of Testosterone Replacement Therapy Drugs Reports Wright & Schulte LLC Columbus, OH (PRWEB) June 20, 2014 As testosterone treatment lawsuits move forward in federal litigation in Illinois, Wright & Schulte LLC has learned that the U.S. Food & Drug Administration (FDA) is now requiring manufacturers of testosterone therapy products to expand...

2014-05-12 11:38:13

Intermountain Medical Center Study included 2,600 AFib patients A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range. The study of more than 2,600 AFib patients found they are significantly more likely to develop dementia when using medicines to prevent blood...

2014-04-21 23:00:12

Interventional cardiologists and electrophysiologists at Allegheny General Hospital recently performed the first procedure using the LARIAT™ Suture Delivery Device, a lasso-like suture that ties off the left atrial appendage (LAA), an area of the heart that is prone to developing blood clots, particularly in patients with atrial fibrillation. Pittsburgh, PA (PRWEB) April 22, 2014 Allegheny General Hospital (AGH), part of Allegheny Health Network, has joined a select group of medical...

2014-03-31 08:29:45

RARITAN, N.J., March 31, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today it is adding three new clinical trials to its EXPLORER global cardiovascular research program for XARELTO(®) (rivaroxaban), the most studied and broadly indicated oral Factor Xa inhibitor in the world today. The additional trials will evaluate rivaroxaban for the treatment or prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in pediatric and other patient...

2014-03-20 00:21:35

Insufficient medical care of blood clots in the extremities is prevalent, but Dr. Malekmehr of the California Institute for Deep Venous Thrombosis takes an active approach LOS ANGELES, March 19, 2014 /PRNewswire/ -- A blood clot in the lower part of the body, or deep vein thrombosis, is a well-known but often misunderstood syndrome despite its potentially grave consequences. Fortunately, widely respected board certified cardiovascular surgeon Dr. Farshad Malekmehr of the California...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related